Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Upcoming Events

Vial will be at the 64th ASH Annual Meeting
Vial is proud to attend the 64th American Society of Hematology Annual Meeting.

Past Events

DPHARM Vial will be at the SITC 37th Annual Meeting
Vial is proud to be an exhibitor at the Society for Immunotherapy of Cancer 37th Annual Meeting. Come visit us at Booth #645.
Vial will be at WIN Symposium 2022
Vial is proud to attend the WIN 2022 Symposium.
Vial will be at ENA 2022 34th Symposium
Vial is proud to attend ENA 2022; the EORTC NCI AACR 34th Symposium.
Vial will be at Cell & Gene Meeting on the Mesa
Vial is proud to attend Cell & Gene Meeting on the Mesa.
onc_web Webinar: Tech-Enabled Oncology Clinical Trials — Delivering Faster, Higher Quality Trials for Sponsors
Join Vial CEO, Simon Burns, as he discusses tech-enabled oncology clinical trials. In this webinar we will cover clinical technologies such as eSource, centralized monitoring, and modern patient experiences and how Vial can deliver faster, higher quality trials for sponsors.
vial boston Vial will be at the Clinical Operations in Oncology Trials East Coast 2022
We’re looking forward to connecting with you at Clinical Operations in Oncology Trials East Coast 2022! Come meet us at booth #9.
Chicago Vial will be at the ASCO 2022 Annual Meeting
If you missed us at ASCO 2022 Annual Meeting, contact us using the form below.
Vial will be at AACR Annual Meeting 2022
Vial is proud to attend the American Association for Cancer Research Annual Meeting 2022.